Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Summary from the Annual General Meeting 2018 of TF Bank

TF Bank AB (publ) held its Annual General Meeting on 2 May 2018. The Annual General Meeting resolved in accordance with all proposals of the Board and the Nomination Committee.At the Annual General Meeting of TF Bank (publ) on Wednesday 2 May 2018 it was resolved, in accordance with the proposal from the Board of Directors, that a dividend for the fiscal year of 2017 shall be paid to the shareholders of SEK 2,25 per share. The record date was set as 4 May 2018. The dividend payment is made through Euroclear Sweden AB and is expected to take place on 9 May 2017. The balance sheets and income

Annual General Meeting in Capio AB

At the Annual General Meeting in Capio AB (publ) held today mainly the following was resolved.Election of Board of Directors, auditor and fees The AGM re-elected Michael Wolf, Michael Flemming, Gunnar Németh, Hans Ramel, Pascale Richetta, Joakim Rubin, Gunilla Rudebjer and Birgitta Stymne Göransson as ordinary members of the Board. Michael Wolf was re-elected Chairman of the Board. The accounting firm Ernst & Young AB was, in accordance with the recommendation of the Finance and Audit Committee, re-elected as auditor, whereby the accounting firm has informed that the authorised public

Cantargia receives patent approval in Canada and broadens protection with respect to hematological cancer

Cantargia AB (“Cantargia”) today announces that the Canadian patent office (“CIPO”) has formally granted the company’s application for a patent protecting a method of using IL1RAP as target molecule for antibody-based therapy and leukemia diagnostics.The approved patent, with patent number CA 2,772,111, refers to Cantargia’s method of using IL1RAP as target molecule for antibody-based therapy and leukemia diagnostics. The patent is valid until 2030 and covers the company’s antibody treatment for several forms of leukemia. Cantargia has previously had equivalent patents for IL1RAP

MIPS: Invitation to the presentation of the results for the period January – March 2018

MIPS releases its first quarter 2018 Interim report on May 9 at 7:30 (CET).Johan Thiel, President and CEO and Max Strandwitz CFO, will present the results the same day at 10:00 CET, at a conference call. The conference call will be held in English. The Interim report and a presentation will be available at www.mipscorp.com/investors.   To participate in the conference call and to obtain call-in details, please register on the following link: http://emea.directeventreg.com/registration/9179329   For Information Max Strandwitz, CFO, phone: +46 709 611 754 or mail Max.Strandwitz@

Resolutions at the Annual General Meeting in Medivir on 3 May 2018

Approval of profit and loss accounts and balance sheets, and discharge from liability of the board members and the managing directorThe annual general meeting in Medivir Aktiebolag (publ) on 3 May 2018 resolved to approve the profit and loss account and balance sheet as well as the consolidated profit and loss account and consolidated balance sheet for the financial year 2017. The persons who had been board members and managing director were discharged from liability with respect to their respective management of the company for the financial year 2017. Appropriation of the company’s

Saab Technology Features in Royal Navy led Information Warfare Exercise

Saab has contributed two innovations systems to the UK’s second-ever Information Warrior exercise.Saab’s 9LV Combat Management System (CMS) and TactiCall Integrated Communication System (ICS) were successfully used in the Information Warrior 18 (IW18) event, which was led by the Royal Navy and industry. The exercise was held at Royal Marine Barracks Stonehouse and British multinational defence technology company QinetiQ’s Portsdown Technology Park and aimed to drive the future development of warfare capabilities, focusing on the computerised side of modern warfare. “IW18 has more than

#18-757 Recalculation of reference value for certain instruments with Tesla Motors Inc. as underlying security

The reference value for certain certificates with Tesla Motors Inc. as underlying has been recalculated in accordance with the instruments final terms. This applies to the following instruments: Symbol: BULL TSLA X10 V3 Symbol: BULL TSLA X10 V2 Symbol: BULL TSLA X10 VThe instrument will be traded under observation for the duration of this trading day. For more information concerning the recalculation, please contact the issuer of the affected instruments. For further information concerning this NGM notice please contact: NGM market surveillance, +46 8 566 390 55,

Enea lists bonds on Nasdaq Stockholm

As previously communicated, Enea AB (publ) (“Enea” or the “Company”) has resolved to list bonds on Nasdaq Stockholm. Nasdaq Stockholm has approved Enea’s application for admission to trading of the bonds and the first day of trading is 4 May 2018. On February 26, 2018, Enea announced that the Company had issued a senior unsecured bond loan in the amount of SEK 500 million with a floating rate coupon of 3 month Stibor + 5.25% and a final maturity in March 2021. On 2 May 2018, Enea published a prospectus and announced that the Company had applied for admission to trading in the bonds on

Report from Concentric AB’s Annual General Meetingon 3 May 2018

Concentric AB’s AGM was held today Thursday 3 May 2018. The main resolutions passed were the following. Regarding full details of the resolutions, a referral is made to the notice convening the AGM and the complete proposals. The notice convening the AGM and the complete proposals are available at the company’s website, www.concentricab.com. Adoption of the income statements and the balance sheets The meeting resolved to adopt the income statement and balance sheet and the consolidated income statement and consolidated balance sheet for the financial year 2017. Dividend   The

Press release from the Annual General Meeting in Arise AB (publ) on 3 May, 2018

At the Annual General Meeting on 3 May, 2018 in Arise AB (publ) it was resolved; · to adopt the profit and loss statement and balance sheet, consolidated profit and loss statement and consolidated balance sheet,   · not to distribute any dividend for the financial year 2017, · that remuneration to the Board of Directors and its Committees will be paid with SEK 1,675,000 in total and the Auditor’s fee was resolved to be paid in accordance with customary standards and approved invoice,  · to re-elect the Board members Jon Brandsar, Joachim Gahm, Peter Gyllenhammar and Maud

Shareholder diclosure

Geveran Trading Co. Limited ("Geveran"), a company indirectly controlled by trusts established by Mr. John Fredriksen for the benefit of his immediate family, has on 3 May 2018 acquired 13,000,000 shares in Axactor AB (publ) ("Axactor") at a purchase price of NOK 2.69 per share. Following the acquisition, Geveran will own 186,902,500 shares in Axactor which will constitute 12.10% of the shares and votes in Axactor. Geveran also holds 130,000,000 warrants exchangeable into 130,000,000 ordinary shares in Axactor (the "Warrants"). The Warrants entitles Geveran to subscribe Axactor shares

Shareholder diclosure

Geveran Trading Co. Limited ("Geveran"), a company indirectly controlled by trusts established by Mr. John Fredriksen for the benefit of his immediate family, has on 3 May 2018 acquired 13,000,000 shares in Axactor AB (publ) ("Axactor") at a purchase price of NOK 2.69 per share. Following the acquisition, Geveran will own 186,902,500 shares in Axactor which will constitute 12.10% of the shares and votes in Axactor. Geveran also holds 130,000,000 warrants exchangeable into 130,000,000 ordinary shares in Axactor (the "Warrants"). The Warrants entitles Geveran to subscribe Axactor shares

Vestas - Disclosure requirement regarding share capital and number of votes as per 3 May 2018

Vestas Wind Systems A/S, Aarhus, 3 May 2018Company announcement No. 22/2018 Disclosure requirement regarding share capital and number of votes as per 3 May 2018  As per announcement of 3 May 2018, Vestas Wind Systems A/S has completed a capital reduction of nominally DKK 9,800,944 representing 9,800,944 shares of nominally DKK 1 each in connection with cancellation of treasury shares. Pursuant to section 10 of Executive Order No. 1526 of 9 December 2016 on Issuers’ Disclosure Obligations, we are pleased to confirm that as at 3 May 2018, Vestas Wind Systems A/S has a share capital

Axel Johnson International acquires Dutch mechanical power transmission company

Axel Johnson International’s Industrial Solutions business group is increasing its market presence in the Netherlands through the acquisition of MAK Aandrijvingen B.V., effective May 2. MAK, located in Lelystad, provides power transmission solutions including chains, belts, motors and reducers to OEM customers.“As a value-adding distributor for leading OEM’s, MAK has developed a strong niche position,” says Ola Sjölin, Managing Director Industrial Solutions. “MAK will be a great addition to our existing business in the Dutch market and an important piece in our ambition to continue grow

Major shareholder announcement – Vestas Wind Systems A/S

Vestas Wind Systems A/S, Aarhus, 3 May 2018Company announcement No. 21/2018 Major shareholder announcement – Vestas Wind Systems A/S  In accordance with section 31 of the Danish Capital Markets Act, Vestas Wind Systems A/S (Vestas) discloses that at 3 May 2018, Vestas holds, through direct holdings, 5,207,666 shares in Vestas, corresponding to 2.5 percent of the shares in Vestas. Contact detailsVestas Wind Systems A/S, DenmarkPatrik Setterberg, Vice President                                         Investor RelationsTel: +45 6122 1913

NOTICE TO ATTEND THE ANNUAL GENERAL MEETING OF IRRAS AB (PUBL)

The shareholders in IRRAS AB (publ), reg. no. 556872-7134, are hereby invited to attend the annual general meeting (“AGM”) to be held on Friday, June 1, 2018 at 11.00 am at IVA Konferenscenter, Grev Turegatan 16 in Stockholm, Sweden. Notification to attend etc. Shareholders who wish to attend the AGM must · be recorded in the share register kept by Euroclear Sweden AB no later than on Friday 25 May 2018; and · notify the company of their intention to attend the AGM at the latest by Monday, May 28, 2018. Notification to participate in the AGM must be in writing via the

Gränges to restart production in Newport, Arkansas – investment of USD 26 million

Gränges has decided to restart production at its Newport, Arkansas facility focused on light gauge aluminium foil for various consumer applications. In total, the investment amounts to USD 26 million. "This is a good opportunity for us to upgrade and use the assets we already own, and address an attractive market niche which has been mainly served through imports. We expect the investment to make a positive contribution to earnings in 2019 and beyond, "says Gränges CEO Johan Menckel. The investment relates to upgrading existing rolling mills and equipment. The facility in Newport

Loomis Interim report January – March 2018

January – March 2018Revenue for the first quarter amounted to SEK 4,486 million compared to SEK 4,279 million the corresponding period the previous year. Organic growth was 3 percent (3) and real growth was 8 percent (3). Loomis operating income (EBITA)[1] amounted to SEK 472 million (462) and the operating margin was 10.5 percent (10.8). Income before taxes amounted to SEK 425 million (405) and income after taxes was SEK 318 million (290). Earnings per share before and after dilution amounted to SEK 4.22 (3.85). Cash flow from operating activities amounted to SEK 271 million (

Alligator Bioscience: ATOR-1017 pre-clinical data support a best-in-class 4-1BB antibody profile

-        Unique binding profile and cross-linking properties-        Oral presentation at Protein Engineering Summit in Boston, USLund, Sweden, 3 May 2018 – Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, will present pre-clinical data for the drug candidate ATOR-1017 at the Protein Engineering Summit (PEGS) 14th Annual Meeting in Boston, US. ATOR-1017 is a monoclonal antibody that activates the costimulatory receptor 4-1BB expressed on T cells in the tumor area and is being developed for

Press release from the annual shareholders’ meeting in Smart Eye on 25 April 2018

The press release is only available in Swedish, as follows. Nedan följer en sammanfattning av de beslut som fattades av årsstämman avseende verksamhetsåret 2017-01-01 – 2017-12-31.Vid årsstämman i Smart Eye Aktiebolag (publ) i Göteborg den 25 april 2018 beslutades följande: • Arvode till styrelsen. 125 000 kr till styrelseordförande och 125 000 kr till övriga styrelseledamöter. • Val av styrelse enligt följande: o Anders Jöfelt (omval) – styrelseordförande o Mats Krantz (omval) o Magnus Jonsson (omval) o Staffan Hansson (omval) o Per Aniansson (omval) o Lars

Isofol reports FDAs feedback from the ongoing special protocol assessment (SPA) process

In March 2018, Isofol Medical AB (publ) submitted a Special Protocol Assessment (SPA) to the United States Food and Drug Administration (FDA). The SPA process aims to confirm the specific targets to be met in the ISO-CC-007 study, the pivotal study with arfolitixorin in first line metastatic colorectal cancer (mCRC).  In the feedback received from the FDA the company has reached a consensus with the FDA on the most important parameters for an SPA agreement and will now complete the SPA submission with the outstanding issues commented on by the FDA.The FDA agreed: ·  that the primary

Loudspring Releases Environmental Impact Report: 1€ portfolio company revenue = 8 kg of CO2 and 0.8 m3 of water saved

Loudspring has calculated the carbon and water impact of a select group of its portfolio for the second year. The results show that a total of 157 969 ton CO2 emissions were avoided, and 13 726 983 m3 of water was saved through products or services sold by the portfolio in 2017. Results were derived using data from six of their main holdings: Eagle Filters, Swap.com, ResQ Club, Sofi Filtration, Enersize and Nuuka Solutions. Eagle Filters (filtration for intake air in natural gas power plants) was the best performing holding for CO2 and overall impact this year, reporting 121 510 tons

Reduction of share capital in Vestas Wind Systems A/S by cancellation of treasury shares

Vestas Wind Systems A/S, Aarhus, 3 May 2018Company announcement No. 20/2018 Reduction of share capital in Vestas Wind Systems A/S by cancellation of treasury shares On 3 April 2018, the Annual General Meeting of Vestas Wind Systems A/S adopted the proposal to reduce Vestas' share capital by nominally DKK 9,800,944 by cancelling 9,800,944 shares from Vestas’ holding of treasury shares. The reduction of the share capital has been completed and registered today. After the reduction, Vestas Wind Systems A/S' share capital amounts to nominally DKK 205,696,003, corresponding to 205,696,

There are no items matching the current filter
There are no more items matching the current filter
Back to top